Hjem › Akut myelogen leukemi › New Jersey › Edison
Kliniske studier for Akut myelogen leukemi i Edison, NJ
20 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
A Study of CRD3874-SI in People With Leukemia
RekruttererFase 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi unna
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi unna
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi unna
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
RekruttererFase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi unna
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
RekruttererFase 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of Revumenib and Mezigdomide in People With Leukemia
RekruttererFase 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
RekruttererFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi unna
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
RekruttererFase 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Baldwin Park, CA40 studier
- Seattle, WA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA30 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andre studier i Edison
- Brystkreft68 studier
- Ikke-småcellet lungekreft47 studier
- Kreft (alle typer)33 studier
- Prostatakreft29 studier
- Kolorektal kreft23 studier
- Lungekreft23 studier
- Multipelt myelom22 studier
- Blærekreft21 studier
- Metastatisk kreft20 studier
- Eggstokkreft20 studier
- Endometriekreft19 studier
- Urotelial (overgangscelle) karcinom18 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.